Clinical Social Workers in Brown Deer, WI Accepting Medicare

32 Clinical Social Workers found. Showing 21 - 32

Eliese Christine Rucktenwald, M.S.W., LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 3900 W Brown Deer Rd, Suite 200, Brown Deer, WI 53209 Phone: 414-540-1270    Fax: 414-540-2171

Sarah Sleider Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170

Carly Bolli Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170

Lori Eskenazi, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd, Brown Deer, WI 53209 Phone: 414-540-2170

Bethany Hokkanen Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170    Fax: 414-540-2171

Kelli Zelinger Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170

Erin Shannon Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170

Ashlea Pardee Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170

Laurel Cotton, MSW, APSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5600 W Brown Deer Rd, Suite 110, Brown Deer, WI 53223 Phone: 414-333-2749

Jasmine Stocki Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170

Sonya Behan Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170

Ms. Clare Ann Lewis, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 3900 W Brown Deer Rd, Suite 200, Brown Deer, WI 53209 Phone: 414-540-2170    Fax: 414-540-2171

News Archive

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

The U.S. Food and Drug Administration today approved Invokana (canaglifozin) tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes.

Viewpoints: Fears of health law's adverse selection; GOP's 'fundamental miscalculation;' special deal for Congress keeps dissent low

Yet despite the care the administration took in establishing incentives and safeguards, even some of Obamacare's most committed backers are wondering whether the experiment will work as advertised -; or, like Harvard's P.P.O., go off the rails along the way. Adverse selection is perhaps the direst threat. ... Healthier Americans will probably flock to cheaper bronze plans. And insurers will vie to enroll the healthy. In some states, big insurers have chosen not to participate in exchanges to avoid their strictures. On the outside, they could still sell cheap plans to skim off the healthy and avoid a rule that insurers on the exchanges must also offer more generous silver and gold plans (Eduardo Porter, 8/7).

High prevalence of cross-reactive anti-SARS-CoV-2 antibodies in sub-Saharan Africa

A recent study published in the International Journal of Infectious Diseases has explained the lower prevalence of coronavirus disease 2019 (COVID-19) in sub-Saharan Africa compared to that in the US, Europe, and Asia.

Study reveals inaccuracy of exercise test that could lead to unnecessary open heart surgeries

An approved international test to check whether people need open heart surgery could be sending twice as many people under the knife unnecessarily, at a cost of nearly £75m, research by the University of Leicester has suggested.

Positive results from new analyses of denosumab Phase 3 trials

Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.

Read more Medical News

› Verified 1 days ago

• 1
• 2(current)